前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービス
文献複写のお申込み
JDreamⅢ複写サービスのご利用が初めての方
学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201702234224432565   整理番号：17A1181382

磁気共鳴イメージング限定された前立腺癌に対するデュタステリドの効果:写像:無作為化,プラセボ対照二重盲検臨床試験【Powered by NICT】

The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical Trial
著者 (120件)：
Moore Caroline M.
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Moore Caroline M.
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Moore Caroline M.
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Moore Caroline M.
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Moore Caroline M.
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Moore Caroline M.
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Moore Caroline M.
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Moore Caroline M.
(Klarismo (BJW), United Kingdom)
, 
Moore Caroline M.
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Moore Caroline M.
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Moore Caroline M.
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Moore Caroline M.
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Robertson Nicola L.
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Robertson Nicola L.
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Robertson Nicola L.
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Robertson Nicola L.
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Robertson Nicola L.
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Robertson Nicola L.
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Robertson Nicola L.
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Robertson Nicola L.
(Klarismo (BJW), United Kingdom)
, 
Robertson Nicola L.
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Robertson Nicola L.
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Robertson Nicola L.
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Robertson Nicola L.
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Jichi Fatima
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Jichi Fatima
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Jichi Fatima
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Jichi Fatima
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Jichi Fatima
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Jichi Fatima
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Jichi Fatima
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Jichi Fatima
(Klarismo (BJW), United Kingdom)
, 
Jichi Fatima
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Jichi Fatima
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Jichi Fatima
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Jichi Fatima
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Damola Adebiyi
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Damola Adebiyi
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Damola Adebiyi
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Damola Adebiyi
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Damola Adebiyi
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Damola Adebiyi
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Damola Adebiyi
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Damola Adebiyi
(Klarismo (BJW), United Kingdom)
, 
Damola Adebiyi
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Damola Adebiyi
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Damola Adebiyi
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Damola Adebiyi
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Ambler Gareth
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Ambler Gareth
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Ambler Gareth
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Ambler Gareth
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Ambler Gareth
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Ambler Gareth
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Ambler Gareth
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Ambler Gareth
(Klarismo (BJW), United Kingdom)
, 
Ambler Gareth
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Ambler Gareth
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Ambler Gareth
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Ambler Gareth
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Giganti Francesco
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Giganti Francesco
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Giganti Francesco
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Giganti Francesco
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Giganti Francesco
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Giganti Francesco
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Giganti Francesco
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Giganti Francesco
(Klarismo (BJW), United Kingdom)
, 
Giganti Francesco
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Giganti Francesco
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Giganti Francesco
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Giganti Francesco
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Ridout Ashley J.
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Ridout Ashley J.
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Ridout Ashley J.
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Ridout Ashley J.
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Ridout Ashley J.
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Ridout Ashley J.
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Ridout Ashley J.
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Ridout Ashley J.
(Klarismo (BJW), United Kingdom)
, 
Ridout Ashley J.
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Ridout Ashley J.
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Ridout Ashley J.
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Ridout Ashley J.
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Bott Simon R.J.
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Bott Simon R.J.
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Bott Simon R.J.
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Bott Simon R.J.
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Bott Simon R.J.
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Bott Simon R.J.
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Bott Simon R.J.
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Bott Simon R.J.
(Klarismo (BJW), United Kingdom)
, 
Bott Simon R.J.
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Bott Simon R.J.
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Bott Simon R.J.
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Bott Simon R.J.
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Winkler Mathias
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Winkler Mathias
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Winkler Mathias
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Winkler Mathias
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Winkler Mathias
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Winkler Mathias
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Winkler Mathias
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Winkler Mathias
(Klarismo (BJW), United Kingdom)
, 
Winkler Mathias
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Winkler Mathias
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Winkler Mathias
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Winkler Mathias
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)
, 
Ahmed Hashim U.
(Division of Surgery and Interventional Science (CMM, NLR, AD, AJR, HUA, MA, ME), University College London, United Kingdom)
, 
Ahmed Hashim U.
(Biostatistics Group, University College London Hospitals/University College London Research Support Centre (FJ, GA), University College London, United Kingdom)
, 
Ahmed Hashim U.
(Department of Urology, University College London Hospitals National Health Service Foundation Trust (CMM, NLR, AD, AJR, HUA, MA, NM, ME), United Kingdom)
, 
Ahmed Hashim U.
(Department of Radiology (FG, CA), University College London Hospital Trust, United Kingdom)
, 
Ahmed Hashim U.
(Department of Pathology (AF, CJ), University College London Hospital Trust, United Kingdom)
, 
Ahmed Hashim U.
(Department of Urology, Charing Cross Hospital, Imperial College National Health Service Trust (MW), United Kingdom)
, 
Ahmed Hashim U.
(Department of Clinical Oncology, University College Hospital London (AVM), United Kingdom)
, 
Ahmed Hashim U.
(Klarismo (BJW), United Kingdom)
, 
Ahmed Hashim U.
(Department of Mathematics, Imperial College London (BJW), United Kingdom)
, 
Ahmed Hashim U.
(Department of Urology, Frimley Park Hospital, Surrey (SRJB), United Kingdom)
, 
Ahmed Hashim U.
(GlaxoSmithKline Research and Development (RC), Philadelphia, Pennsylvania)
, 
Ahmed Hashim U.
(Institut National de la Sante et de la Recherche Medicale, U1099 and Laboratoire Traitement du Signal et de l’Image, Universite de Rennes 1, Rennes (GG), France)

資料名：
Journal of Urology  (Journal of Urology)

巻： 197  号： 4  ページ： 1006-1013  発行年： 2017年 
JST資料番号： B0074B  ISSN： 0022-5347  CODEN： JOURA  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

Copyright (c) 2009 Japan Science and Technology Agency. All Rights Reserved

TOP

BOTTOM